儿童急性淋巴细胞白血病：希腊一家中心采用柏林-法兰克福-明斯特方案的12年经验。 - Suppr | 超能文献

Childhood acute lymphoblastic leukemia: 12 years of experience, using a Berlin-Frankfurt-Münster approach, in a Greek center.

作者信息

Ampatzidou Maria, Panagiotou John P, Paterakis Georgios, Papadakis Vassilios, Papadhimitriou Stephanos I, Parcharidou Agapi, Papargyri Sophia, Rigatou Efthimia, Avgerinou Georgia, Tsitsikas Konstantinos, Vasdekis Vassilios, Haidas Stavros, Polychronopoulou Sophia

机构信息

Department of Pediatric Hematology-Oncology, "Aghia Sophia" Children's Hospital , Athens , Greece.

出版信息

Leuk Lymphoma. 2015 Jan;56(1):251-5. doi: 10.3109/10428194.2014.916801. Epub 2014 Jun 27.

DOI:10.3109/10428194.2014.916801

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Childhood acute lymphoblastic leukemia: 12 years of experience, using a Berlin-Frankfurt-Münster approach, in a Greek center.儿童急性淋巴细胞白血病：希腊一家中心采用柏林-法兰克福-明斯特方案的12年经验。

Leuk Lymphoma. 2015 Jan;56(1):251-5. doi: 10.3109/10428194.2014.916801. Epub 2014 Jun 27.

2

Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.miR-143/miR-182 水平在 BFM 治疗儿童急性淋巴细胞白血病预后和危险分层特异性中的临床应用

Ann Hematol. 2018 Jul;97(7):1169-1182. doi: 10.1007/s00277-018-3292-y. Epub 2018 Mar 20.

3

Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of Germany.儿童白血病：德意志联邦共和国的柏林-法兰克福-明斯特合作试验

J Cancer Res Clin Oncol. 1990;116(1):100-3. doi: 10.1007/BF01612648.

4

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.头颅放疗在高白细胞计数且对泼尼松反应良好的儿童T细胞急性淋巴细胞白血病中的作用。意大利儿科血液学肿瘤学协会和柏林-法兰克福-明斯特研究组。

J Clin Oncol. 1997 Aug;15(8):2786-91. doi: 10.1200/JCO.1997.15.8.2786.

5

Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic.基于 ALL-BFM 90、95 方案和 ALL IC-BFM 2002 方案治疗儿童急性淋巴细胞白血病的疗效和预后：捷克奥洛穆茨的单中心回顾性研究。

Neoplasma. 2016;63(3):456-61. doi: 10.4149/316_150910N482.

6

Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.柏林-法兰克福-明斯特集团急性淋巴细胞白血病复发研究（ALL-REZ BFM）经验：早期治疗强度至关重要。

J Clin Oncol. 2004 Feb 1;22(3):569-70; author reply 570-1. doi: 10.1200/JCO.2004.99.153.

7

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.在基于柏林-法兰克福-明斯特方案的间歇治疗中，大剂量阿糖胞苷对高危急性淋巴细胞白血病和淋巴细胞淋巴瘤儿童的价值：欧洲癌症研究与治疗组织58881随机III期试验结果

J Clin Oncol. 2001 Apr 1;19(7):1935-42. doi: 10.1200/JCO.2001.19.7.1935.

8

Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.奥地利儿童及青少年恶性非霍奇金淋巴瘤——1986年至2000年的治疗结果

Wien Klin Wochenschr. 2002 Dec 30;114(23-24):978-86.

9

Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.儿童和青少年非霍奇金淋巴瘤：根据生物学亚型和分期分层治疗的结果——柏林-法兰克福-明斯特集团报告

J Clin Oncol. 1995 Feb;13(2):359-72. doi: 10.1200/JCO.1995.13.2.359.

10

The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.最大支持性治疗对剂量依从性和生存的影响。1984年至1993年期间治疗的儿童急性淋巴细胞白血病和非霍奇金淋巴瘤的单中心分析。

Klin Padiatr. 1997 Jul-Aug;209(4):235-42. doi: 10.1055/s-2008-1043956.

引用本文的文献

1

Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies.癌症患儿心脏毒性的预后因素：定义、病因及组学技术诊断

Diagnostics (Basel). 2023 May 26;13(11):1864. doi: 10.3390/diagnostics13111864.

2

The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols.CDKN2A/2B基因缺失在儿童急性淋巴细胞白血病（ALL）中的预后影响：在基于柏林-法兰克福-明斯特（BFM）方案中的独立预后意义

Diagnostics (Basel). 2023 Apr 28;13(9):1589. doi: 10.3390/diagnostics13091589.

3

Copy Number Alteration Profile Provides Additional Prognostic Value for Acute Lymphoblastic Leukemia Patients Treated on BFM Protocols.拷贝数改变图谱为接受BFM方案治疗的急性淋巴细胞白血病患者提供了额外的预后价值。

Cancers (Basel). 2021 Jun 30;13(13):3289. doi: 10.3390/cancers13133289.

4

Proteomic analysis of cerebrospinal fluid in pediatric acute lymphoblastic leukemia patients: a pilot study.小儿急性淋巴细胞白血病患者脑脊液的蛋白质组学分析：一项初步研究。

Onco Targets Ther. 2019 May 17;12:3859-3868. doi: 10.2147/OTT.S193616. eCollection 2019.